Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0007 USD | -12.50% |
|
-12.50% | -46.15% |
02-12 | Balincan USA has Changed its Name to Tekumo, Inc | CI |
2023 | Balincan USA, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023 | CI |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 |
---|---|---|
Net sales 1 | 1.537 | 2.773 |
EBITDA | - | - |
EBIT 1 | -0.1818 | -0.1527 |
Operating Margin | -11.83% | -5.5% |
Earnings before Tax (EBT) 1 | -0.2225 | -0.2036 |
Net income 1 | -0.2225 | -0.2036 |
Net margin | -14.48% | -7.34% |
EPS | - | -0.001355 |
Free Cash Flow | - | -0.5223 |
FCF margin | - | -18.83% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 9/23/22 | 9/23/22 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 |
---|---|---|
Net Debt 1 | 0.46 | 1.06 |
Net Cash position 1 | - | - |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | -0.52 |
ROE (net income / shareholders' equity) | - | -36% |
ROA (Net income/ Total Assets) | - | -4.96% |
Assets 1 | - | 4.106 |
Book Value Per Share | - | 0 |
Cash Flow per Share | - | 0 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 9/23/22 | 9/23/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-46.15% | 937K | |
+2.81% | 59.96B | |
+15.96% | 15.45B | |
+49.54% | 9.13B | |
-8.40% | 5.05B | |
-29.08% | 3.82B | |
-4.62% | 3.61B | |
-32.75% | 3.32B | |
-4.65% | 3.2B | |
-22.45% | 2.92B |
- Stock Market
- Equities
- TKMO Stock
- Financials Tekumo, Inc.